Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · Real-Time Price · USD

2.240

0.00 (0.00%)

At close: Aug 5, 2026, 4:00 PM EDT

2.290

+0.050 (2.23%)

After-hours: Aug 5, 2026, 7:47 PM EDT

Acumen Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	51.8	53.99	35.63	66.89	130.1	122.16
Short-Term Investments	76.6	62.88	135.93	176.64	47.5	72.08
Cash & Short-Term Investments	128.4	116.87	171.56	243.52	177.61	194.24
Cash Growth	-13.91%	-31.88%	-29.55%	37.11%	-8.56%	343.70%
Other Current Assets	4.7	5.39	6.75	3.09	2.72	4.42
Total Current Assets	133.09	122.25	178.31	246.62	180.33	198.66
Net Property, Plant & Equipment	-	-	-	-	0.27	0.04
Long-Term Investments	-	-	59.97	62.55	15.84	31.62
Other Long-Term Assets	0.54	0.58	0.72	0.96	0.15	0.01
Total Assets	133.63	122.83	238.99	310.13	196.59	230.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.66	0.55	5.65	1.38	1.64	1.09
Accrued Expenses	13.45	20.69	21.96	10.84	6.07	4.06
Short-Term Debt	14.12	8.77	-	-	-	-
Current Portion of Leases	-	-	-	0.76	0.11	-
Total Current Liabilities	29.23	30.01	27.61	12.97	7.81	5.15
Long-Term Debt	16.92	22.4	29.42	29.9	-	-
Other Long-Term Liabilities	-	-	0.15	0.28	-	-
Total Long-Term Liabilities	16.92	22.4	29.57	30.18	-	-
Total Liabilities	46.15	52.4	57.18	43.15	7.81	5.15

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0	0
Additional Paid-in Capital	554.65	516.8	506.99	489.45	359.95	352.98
Accumulated Other Comprehensive Income	0.02	0.08	-0.05	0.31	-0.75	-0.23
Retained Earnings	-467.2	-446.46	-325.13	-222.8	-170.43	-127.57
Total Common Shareholders' Equity	87.48	70.43	181.82	266.97	188.78	225.18
Shareholders' Equity	87.48	70.43	181.82	266.97	188.78	225.18
Total Liabilities & Equity	133.63	122.83	238.99	310.13	196.59	230.33

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	31.05	31.16	29.42	30.65	0.11	0
Net Cash (Debt)	97.35	85.7	142.14	212.87	177.5	194.24
Net Cash Growth	-18.62%	-39.70%	-33.23%	19.93%	-8.62%	343.70%
Net Cash Per Share	1.59	1.42	2.37	4.38	4.37	9.68
Book Value	87.48	70.43	181.82	266.97	188.78	225.18
Book Value Per Share	1.43	1.16	3.03	5.49	4.65	11.23
Tangible Book Value	87.48	70.43	181.82	266.97	188.78	225.18
Tangible Book Value Per Share	1.43	1.16	3.03	5.49	4.65	11.23

SEC Filings: 10-K · 10-Q